ʻIke Nui
ʻO SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), i ʻike ʻia ʻo 2019-nCoV (2019 Novel Coronavirus) kahi maʻi RNA i hoʻopaʻa ʻia hoʻokahi no ka ʻohana coronaviruses.ʻO ia ka hiku o ka coronavirus i ʻike ʻia e hoʻopilikia i ka poʻe ma hope o 229E, NL63, OC43, HKU1, MERS-CoV, a me ka SARS-CoV kumu.
Manaʻo Pair | CLIA (Hopu-Hopu): 9-1 ~ 81-4 |
Maemae | >95% e like me ka mea i hoʻoholo ʻia e SDS-PAGE. |
ʻO ka hoʻopololei ʻana | PBS, pH7.4. |
Waihona | E mālama iā ia ma lalo o nā kūlana sterile ma -20 ℃ a -80 ℃ ma ka loaʻa ʻana.No ka mālama lōʻihi, e ʻoluʻolu e aliquot a mālama.Hōʻalo i nā pōʻai maloʻo a me ka hoʻolulu. |
inoa mea kūʻai | Cat.ʻAʻole | Klone ID |
SARS-COV-2 NP | AB0046-1 | 9-1 |
AB0046-2 | 81-4 | |
AB0046-3 | 67-5 | |
AB0046-4 | 54-7 |
'Ōlelo Aʻo: Hiki i ka Bioantibody ke hoʻololi i ka nui o kāu pono.
1. Pūʻulu Haʻawina ʻo Coronaviridae o ke Kōmike International no ka ʻauhau o nā maʻi maʻi.ʻO nā ʻano coronavirus pili i ka maʻi respiratory acute respiratory syndrome: hoʻokaʻawale i ka 2019-nCoV a kapa ʻia ʻo SARS-CoV-2.Nat.Microbiol.5, 536–544 (2020)
2.Fehr, AR & Perlman, S. Coronaviruses: he hiʻohiʻona o kā lākou replication a me pathogenesis.Nā ʻano hana.Mol.Biola.1282, 1–23 (2015).
3.Shang, J. et al.ʻO ke kumu kumu o ka ʻike ʻana i ka mea hoʻokipa e SARS-CoV-2.Nature https://doi.org/10.1038/ s41586-020-2179-y (2020).